What's breaking now, across thousands of outlets.
A medicine acquired in a $1.3 billion buyout came through in the first of two pivotal studies in diabetic macular edema, though language regarding the drug’s safety stirred debate among analysts.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Roche is entering two fresh partnerships with drug discovery biotechs Atavistik Bio and Earendil Labs to develop new candidates, in a continuation of the Swiss drugmaker’s dealmaking blitz.
(MedPage Today) -- Many patients treated with golimumab (Simponi) for newly diagnosed peripheral spondyloarthritis (pSpA) in a small trial achieved sustained drug-free remission after 10 years of…
A delegation from Washington State in the United States has paid a courtesy call on the Ghana Medical Trust Fund (GMTF) to explore opportunities for partnership and collaboration in healthcare…
Dr. Heidi Overton is appearing before a Senate committee on Thursday for her confirmation hearing as the next commissioner of the Food and Drug Administration.
By: Jennifer Nerkie Kenney President John Dramani Mahama has highlighted Ghana’s newly launched three-tier healthcare programme as part of measures to expand access to essential healthcare services…
ESPN’s Victory Challenge aims to raise $10 million for pediatric cancer research while highlighting 11-year-old Heston's cancer journey.
